Smoking Cessation and Lung Cancer: Oncology Nurses Can Make a Difference

Cantor Center, Research in Nursing and Patient Care Services, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
Seminars in Oncology Nursing 03/2008; 24(1):16-26. DOI: 10.1016/j.soncn.2007.11.008
Source: PubMed


To provide an overview of the impact of smoking after a diagnosis of lung cancer, discuss the relationship between smoking cessation and improved outcomes, present information about tobacco-dependence treatments, reimbursement for these treatments, and resources available for patients and health care professionals.
Published articles, reports, websites, and research studies.
Prevention of tobacco use and cessation are primary ways to prevent lung cancer. However, even after a diagnosis of lung cancer, smoking cessation is important in improving survival and quality of life. Although effective treatments are available to help smokers quit, persistent efforts over repeated contacts may be necessary to achieve long-term cessation.
Oncology nursing action is essential in the identification of and intervention with patients who struggle with tobacco dependence after diagnosis.

Download full-text


Available from: Mary E Cooley,
  • Source
    • "Enforcement of this legislation and assessment of its outcome requires a dedicated evaluation system that needs a multidisciplinary work including all health sectors. In this regard, nurses and nursing organizations are actively involved in developing and supporting other tobacco control centers[9] to promote prevention of tobacco for any use and to promote collaboration with other healthcare organizations, public health, and tobacco-control groups to strengthen tobacco control at all levels.[10] A community health nurse team in collaboration with Isfahan Cardiovascular Research Center, developed a broad model to evaluate the implementation of the Comprehensive Tobacco Control Law in Iran that is reported in this article. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Iran is one of the countries that has ratified the World Health Organization Framework Convention of Tobacco Control (WHO-FCTC), and has implemented a series of tobacco control interventions including the Comprehensive Tobacco Control Law. Enforcement of this legislation and assessment of its outcome requires a dedicated evaluation system. This study aimed to develop a generic model to evaluate the implementation of the Comprehensive Tobacco Control Law in Iran that was provided based on WHO-FCTC articles. Using a grounded theory approach, qualitative data were collected from 265 subjects in individual interviews and focus group discussions with policymakers who designed the legislation, key stakeholders, and members of the target community. In addition, field observations data in supermarkets/shops, restaurants, teahouses and coffee shops were collected. Data were analyzed in two stages through conceptual theoretical coding. Overall, 617 open codes were extracted from the data into tables; 72 level-3 codes were retained from the level-2 code series. Using a Model Met paradigm, the relationships between the components of each paradigm were depicted graphically. The evaluation model entailed three levels, namely: short-term results, process evaluation and long-term results. Central concept of the process of evaluation is that enforcing the law influences a variety of internal and environmental factors including legislative changes. These factors will be examined during the process evaluation and context evaluation. The current model can be applicable for providing FCTC evaluation tools across other jurisdictions.
    Iranian journal of nursing and midwifery research 03/2012; 17(3):244-54.
  • Source

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The effect of low-dose CT screening for lung cancer on smoking habits has not been reported in large randomised controlled trials. This study evaluated the effect on smoking habits of screening with low-dose CT at 1-year follow up in the Danish Lung Cancer Screening Trial (DLCST), a 5-year randomised controlled trial comprising 4104 subjects; 2052 subjects received annual low-dose CT scan (CT group) and 2052 received no intervention (control group). Participants were healthy current and former smokers (>4 weeks since smoking cessation) with a tobacco consumption of >20 pack years. Smoking habits were determined at baseline and at annual screening. Smoking status was verified using exhaled carbon monoxide levels. Lung function tests, nicotine dependency and motivation to quit smoking were assessed. Quit rates and relapse rates were determined at 1-year follow-up for all subjects. At 1 year the quit rates among smokers were 11.9% in the CT group and 11.8% in the control group (p = 0.95). Relapse rates for former smokers were 10.0% and 10.5% in the CT and control groups, respectively (p = 0.81). Significant predictors (p<0.05) for smoking cessation were: high motivation to quit, low dependency, low ratio of forced expiratory volume in 1 s to forced vital capacity, low pack years, higher age, longer period of abstinence and CT findings necessitating 3-month repeat CT scans. Overall, quit rates were similar in the CT and control group at 1-year follow-up, with a net quit rate of 6.0%. Quit rates were higher and relapse rate lower among subjects with initial CT findings that necessitated a repeat scan 3 months later.
    Thorax 05/2009; 64(5):388-92. DOI:10.1136/thx.2008.102475 · 8.29 Impact Factor
Show more